Fourth Sail Capital LP Purchases 527,859 Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

Fourth Sail Capital LP increased its position in Bioceres Crop Solutions Corp. (NASDAQ:BIOX) by 16.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,698,961 shares of the company’s stock after buying an additional 527,859 shares during the period. Bioceres Crop Solutions comprises 6.7% of Fourth Sail Capital LP’s portfolio, making the stock its 6th largest holding. Fourth Sail Capital LP owned approximately 0.06% of Bioceres Crop Solutions worth $22,490,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the company. Stifel Financial Corp boosted its stake in Bioceres Crop Solutions by 33.4% in the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock worth $321,000 after buying an additional 10,224 shares during the last quarter. Ping Capital Management Inc. increased its stake in shares of Bioceres Crop Solutions by 7.3% during the 4th quarter. Ping Capital Management Inc. now owns 44,000 shares of the company’s stock valued at $268,000 after acquiring an additional 3,000 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its holdings in shares of Bioceres Crop Solutions by 49.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company’s stock worth $708,000 after acquiring an additional 29,693 shares during the period. Hedge funds and other institutional investors own 17.68% of the company’s stock.

Bioceres Crop Solutions Trading Down 4.5 %

Shares of BIOX stock opened at $4.02 on Monday. Bioceres Crop Solutions Corp. has a fifty-two week low of $4.00 and a fifty-two week high of $13.54. The firm’s 50 day moving average price is $6.05 and its two-hundred day moving average price is $7.18. The stock has a market cap of $252.10 million, a price-to-earnings ratio of 201.10 and a beta of 0.57. The company has a quick ratio of 0.96, a current ratio of 1.33 and a debt-to-equity ratio of 0.43.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the stock. Lake Street Capital dropped their price target on shares of Bioceres Crop Solutions from $13.00 to $8.00 and set a “buy” rating for the company in a research report on Friday, February 7th. Oppenheimer dropped their price objective on Bioceres Crop Solutions from $13.00 to $12.00 and set an “outperform” rating for the company in a report on Tuesday, January 28th. Finally, Canaccord Genuity Group reduced their target price on Bioceres Crop Solutions from $7.00 to $6.50 and set a “buy” rating on the stock in a report on Thursday, February 13th. Four investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $9.88.

Bioceres Crop Solutions Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.